As E&C moves to mark up user fee package . . .

House Dems Urge Trump To Help Get Drug Pricing In User Fee Package

May 17, 2017 at 5:32 PM
A group of House Democrats wrote to President Donald Trump Monday (May 15) urging him to work with them to attach drug pricing measures to FDA user fee reauthorization legislation, naming Medicare price negotiation, drug maker transparency, a pay-for-delay crackdown, Risk Evaluation and Mitigation Strategies (REMS) reform, and Medicare rebates as possible policies that could be included. The House Energy & Commerce Committee is set to mark up its user fee reauthorization package Thursday (May 18), and while an E&C...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.